Professor Bradley Nelson and researchers at ETH Zurich have created a miniature robot that can be injected into the eye to precisely measure the retina’s oxygen supply. Many diseases, including Glaucoma, can interfere with oxygen delivery to the retina. Rapid diagnosis and treatment is essential in the attempt to preserve vision.
Using a proprietary patented shape discrimination hyperacuity (SDH) test, myVisionTrack enables patients to regularly assess their vision function. myVisionTrack stores test results, tracks disease progression and can automatically alert a healthcare provider if it suspects significant deterioration of visual function in the patient. Clinical studies demonstrate that myVisionTrack’s shape discrimination hyperacuity test has comparable or higher sensitivity and specificity compared to clinically available standard visual function tests for detecting advanced maculopathy from high-risk moderate maculopathy.